MS MuSings

Monthly Online Magazine

by and for those with MS,

Multiple Sclerosis

April 2007

 

 

Homepage

Tables of Contents

Features

Real Life Stories

Poetry

Fiction

FYI

Theme

Tips & Tricks

Our Pride and Joy!

Other Monthly

Durable Goods Exchange

Related Links

Who's in Issue91

 Awards, 91

Ahead to May

Guestbook

Archives

Gallery

Please Visit

The World of MS  MuSings

 

 

 

FYI

 MS in the News

From Stuart

Stu's Views and M.S. Related  News:
Click HERE to view MS articles of interest
Disclaimer: This website and all related pages and blogs is solely my own personal views and research.
I am not an expert in the field of MS nor a medical practitioner
opt-out at any time by simply replying with your request 
=======================================================
As with most everything, financial support is needed to design, host, edit and support this website/blog and this e-newsletter generated on a continuous basis. I hope that you can help with the gift of a sponsor ad or link. You can pay via paypal or check. 
Sponsorship can help to advertise your occupation, your business or show a personal individual link allowing others to see your support of this site. Link can read Your Company name, or for the individual, your name or "Thank You", "Gracías", "Merci" or anything else. Link can be directed to your personal email or elsewhere.
Please help sponsor this e-Newsletter and my website  - click here for more info
 - Thank you -
 
 February 27, '07: Narcoms - New Quality of Life Study
 
Narcoms =
North American Research Committee on Multiple Sclerosis

February 27, 2007
NARCOMS Researchers at St. Joseph’s Hospital & Medical Center (SJHMC) are conducting a research study for the purpose of validating a newly developed MS-specific quality of life questionnaire.

February 27, '07: Vaccinex Announces Antibody Development
 

Vaccinex Announces Antibody Development and Commercialization Alliance in Multiple Sclerosis and Oncology
- Novel Antibody has Potential to Address Unmet Medical Need in Millions of Patients Worldwide -

Last Update: 8:15 AM ET Feb 27, 2007

ROCHESTER, N.Y., Feb 27, 2007 /PRNewswire via COMTEX/ -- Vaccinex, Inc. announced today that it has entered into a collaboration with Teva Pharmaceutical Industries Ltd. to develop and commercialize VX15, a novel human antibody discovered by Vaccinex.


Post-Hoc Data Analyses Published in Annals of Neurology Found COPAXONE(R) Significantly Delayed Accumulated Disability in Male Patients with Primary Progressive Multiple Sclerosis (PPMS)
By BusinessWire
2/27/2007 8:00:53 AM


 

top of page